9 October 2015
Controlling Blood Brain Barrier Integrity: A New Approach for Multiple Sclerosis?
Organised by:
SCI's Biotechnology Group in partnership with the University of Westminster
London, University of Westminster
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
Regulation of blood brain barrier (BBB) integrity is critical for the maintenance of a healthy neural environment, and disruption of the BBB is a common feature in neurological disease. The protein annexin A1 is highly expressed in cerebral microvascular endothelia, where it regulates expression of inter-endothelial tight junction molecules and is required to maintain the permeability barrier to both small molecules and immune cells. Examination of post mortem human tissue from patients with multiple sclerosis revealed the selective and specific loss of annexin A1 from capillary endothelia in otherwise normal appearing tissue, suggesting why a loss of BBB integrity is a feature of multiple sclerosis pathology. Importantly, treatment in vitro and in vivo with annexin A1 was able to restore BBB function, limiting small molecule and immune cell extravasation and suggesting promising new avenues for therapeutic management of multiple sclerosis.Venue and Contact
University of Westminster
University of WestminsterSchool of Life Sciences
115 New Cavendish Street
London W1W 6UW
Please click here for a location map.
SCI Comms Team
Tel: +44 (0) 20 7598 1594
Email: communications@soci.org
Fees
This is a free event, no need to book. Please check this page for any updates or changes before attending the event.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Additional Info
Speaker
Dr Simon McArthur
Dept Biomedical Sciences, University of Westminster